Somatostatinoma

A somatostatinoma is a rare type of tumor that grows in the pancreas. These tumors make too much of a hormone called somatostatin. This hormone can cause problems like diabetes, gallstones, and diarrhea. Doctors often check for these tumors if someone has these symptoms.

Condition

What people with Somatostatinoma report

Every report comes from a Lived member, sent anonymously.

Have you had Whipple Procedure for Somatostatinoma?

NameHow it went

About Somatostatinoma

What It Is

A somatostatinoma is a rare tumor that grows from cells that make somatostatin, a hormone whose normal job is to slow things down. Somatostatin dampens the release of insulin and other digestive hormones, reduces the flow of pancreatic digestive enzymes and slows the gallbladder and gut. These tumors are a type of neuroendocrine tumor, meaning they arise from hormone-producing cells. A little over half start in the pancreas; most of the rest start in the duodenum (the first part of the small intestine), often near the opening where bile and pancreatic juices drain into the gut. When a tumor releases a lot of somatostatin, it can cause a recognizable pattern: new or worsening diabetes, gallstones, and diarrhea or pale, greasy, foul-smelling stools caused by poorly digested fat, often with weight loss. This full pattern is uncommon, and it is seen more often with pancreatic tumors. Tumors in the duodenum more often cause abdominal pain, yellowing of the skin or eyes (jaundice) from a blocked bile duct, or bleeding. Some cause no symptoms and are found by chance on a scan or during surgery for something else. Somatostatinomas matter because they are often found late. Many have already spread, most often to nearby lymph nodes or the liver, by the time they are diagnosed.

Causes & Risk Factors

Most somatostatinomas occur without a known cause. A meaningful share, however, develop as part of an inherited condition that raises the risk of several kinds of tumors. The clearest link is with neurofibromatosis type 1 (NF1), a genetic condition known for light-brown skin patches (cafe-au-lait spots), freckling in the armpits or groin and soft growths on or under the skin. In people with NF1, somatostatinomas usually form in the duodenum, rarely produce the full hormone syndrome and are less likely to spread than tumors that occur on their own. Less often, somatostatinomas occur with multiple endocrine neoplasia type 1 (MEN1), von Hippel-Lindau disease or tuberous sclerosis, each an inherited condition that predisposes to tumors. Because of these links, finding a somatostatinoma usually prompts a look for signs of an underlying syndrome, which can affect screening for other tumors and testing for relatives. Most people are diagnosed in middle or later adulthood, and men and women are affected about equally.

How It's Diagnosed

Because the symptoms overlap with common problems such as diabetes and gallstones, a somatostatinoma is rarely suspected at first. It is usually found when imaging or an endoscopy (a camera passed through the mouth into the stomach and duodenum) is done to investigate pain, jaundice, weight loss or diarrhea. Once a tumor is seen, the work-up has three goals: confirm what it is, find out how far it has spread and look for an inherited cause. A biopsy, often taken during endoscopy or endoscopic ultrasound (an ultrasound probe on the end of an endoscope that gives close views of the pancreas and duodenum), lets a pathologist confirm a neuroendocrine tumor that contains somatostatin and estimate its grade, meaning how fast the cells are dividing. A fasting blood test can show a high somatostatin level, which supports the diagnosis and can be used later to track the tumor, though some tumors do not raise it. Staging relies on contrast CT or MRI of the abdomen. A specialized PET scan using a tracer that attaches to somatostatin receptors (such as a gallium-68 DOTATATE scan) can find spread elsewhere in the body and shows whether the tumor carries these receptors, which helps predict whether some treatments are likely to work. Care is usually planned by a team experienced in neuroendocrine tumors.

Treatment Options

When the tumor has not spread, surgery to remove it is the only treatment that offers a cure. For a tumor in the head of the pancreas or near the bile duct opening, this often means a Whipple procedure, a major operation that removes part of the pancreas, the duodenum, the gallbladder and the end of the bile duct. Removing the gallbladder is commonly part of pancreatic surgery for somatostatinoma because the hormone promotes gallstones. After successful removal, somatostatin levels fall and diarrhea, fatty stools and tumor-related diabetes can improve. When the tumor has spread or cannot be removed, treatment aims to control symptoms and slow growth for as long as possible. Somatostatin analogs are long-acting, lab-made versions of somatostatin given as monthly injections, such as octreotide or lanreotide (Somatuline Depot). It may seem surprising that they help with a tumor that makes somatostatin, but they can reduce the tumor's hormone release, ease diarrhea and weight loss, and may slow tumor growth, as they do in other neuroendocrine tumors. Other options, chosen by the tumor's grade, receptor status and pace, include peptide receptor radionuclide therapy (PRRT, a radioactive drug that travels to tumors carrying somatostatin receptors), targeted cancer drugs such as everolimus or sunitinib, chemotherapy such as capecitabine with temozolomide, and treatments aimed at liver spread, such as ablation or blocking the tumors' blood supply. Surgery to remove much of the tumor can also help some people even when a cure is not possible. Evidence for each of these comes mostly from other neuroendocrine tumors and small case series, because somatostatinoma is so rare. Everolimus can worsen blood sugar control, which matters for someone who already has diabetes from the tumor. Supportive care is part of treatment. Fatty stools may call for pancreatic enzyme capsules taken with meals, smaller low-fat meals and vitamin A, D, E and K supplements, and a dietitian can help reverse weight loss. Diabetes is treated as it would be otherwise, with attention to how it changes as the tumor is treated.

What to Expect

Outlook depends mainly on the tumor's grade, how far it has spread and whether it can be completely removed. People whose tumor is found while still localized and slow-growing, and is fully removed, generally do best. Because the condition is so rare, there are not enough data to give reliable survival figures, and many people are diagnosed after the tumor has reached the liver, when treatment usually controls rather than cures it. Even then, the outlook is not uniform: survival can be long, particularly for slow-growing duodenal tumors, while faster-growing tumors are harder to control. Follow-up is long: typically regular visits, somatostatin blood levels and scans every 6 to 12 months, more often in the first year, continuing for up to 10 years after surgery. People with NF1 or another inherited syndrome also need ongoing screening for the other tumors that syndrome can cause.

When to Seek Help

See a clinician if you develop diabetes along with unexplained diarrhea, greasy stools or weight loss, especially if you also have gallstones or a condition such as NF1. Contact your care team promptly if your skin or eyes turn yellow, your urine darkens or your stools turn pale, since this can mean the bile duct is blocked. Get medical care right away for black or bloody stools, vomiting blood, or severe abdominal pain with persistent vomiting, which can signal bleeding from the tumor or inflammation of the pancreas.

Questions to Ask Your Doctor

  1. 1.Where is my tumor, what is its grade and stage, and can it be completely removed?
  2. 2.Does my tumor show up on a somatostatin receptor scan, and how does that affect my treatment options?
  3. 3.Should I be evaluated for NF1 or another inherited condition, and should my relatives be tested?
  4. 4.How will treatment affect my digestion and blood sugar, and will I need enzyme capsules or diabetes medicine?
  5. 5.Is there a center with experience in neuroendocrine tumors where my care should be planned or reviewed?

Last reviewed • Oct 2026

Educational content, not medical advice.